Literature DB >> 6629971

Menstrual dysfunction in cystic fibrosis.

L S Neinstein, D Stewart, C I Wang, I Johnson.   

Abstract

Several factors potentially involved in the menstrual dysfunction of some females with cystic fibrosis were analyzed by a retrospective chart review. The mean age of menarche for the cystic fibrosis patients was 14.4 years, compared to 12.9 years for American females (p less than 0.001). At last evaluation, comparison of the mean figures for amenorrheic patients and for menarchal cystic fibrosis patients reveals statistically significant differences in the age of diagnosis, weight-height index, weight, height, percent of body fat, weight percentile, and height percentile. The highest correlative was weight (r = 0.59). Of our cystic fibrosis patients who were menarchal, 95% had a weight greater than 82 pounds, whereas 75% of those who were amenorrheic weighed less than 82 pounds. Menstrual irregularities, sexual activity, and contraceptive use among these patients also is discussed.

Entities:  

Keywords:  Age Factors; Amenorrhea; Biology; Body Weight; Contraceptive Usage; Data Analysis; Decision Making; Demographic Factors; Diseases; Dysmenorrhea; Menarche; Menstruation; Menstruation Disorders; Physiology; Population; Population Characteristics; Psychosocial Factors; Pulmonary Effects; Reproduction; Research Methodology; Sex Behavior

Mesh:

Substances:

Year:  1983        PMID: 6629971     DOI: 10.1016/s0197-0070(83)80367-2

Source DB:  PubMed          Journal:  J Adolesc Health Care        ISSN: 0197-0070


  9 in total

Review 1.  Women with cystic fibrosis and their potential for reproduction.

Authors:  F P Edenborough
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

2.  Contraception and pregnancy in cystic fibrosis.

Authors:  J G Thorpe-Beeston
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

3.  Menarche in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Eric Vittinghoff
Journal:  Dig Dis Sci       Date:  2012-06-29       Impact factor: 3.199

Review 4.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

Review 5.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

Review 6.  Menstrual dysfunction in pathophysiologic states.

Authors:  L S Neinstein
Journal:  West J Med       Date:  1985-10

Review 7.  Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.

Authors:  Natalie E West; Traci M Kazmerski; Jennifer L Taylor-Cousar; Vin Tangpricha; Kelsie Pearson; Moira L Aitken; Raksha Jain
Journal:  Pediatr Pulmonol       Date:  2021-10-08

8.  Multidisciplinary approach to patients with manifestations and pulmonary complications of cystic fibrosis.

Authors:  Viorel Biciuşcă; Ileana Octavia Petrescu; Cristina Elena Singer; Anca Gabriela Oancea; Ana Maria Petrescu; Ionelia Sorina Stan; Patricia Durand; Citto Iulian Taisescu; Daniela Dumitrescu; Mihaela Amelia Dobrescu; Ion Udriştoiu; Diana Rodica Tudoraşcu; Florin Petrescu
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

Review 9.  Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.

Authors:  Raksha Jain; Jennifer L Taylor-Cousar
Journal:  J Pers Med       Date:  2021-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.